SCHEMBL14976923

SCHEMBL14976923

Cc1c(-c2ccc3c(c2)OCO3)ccn(C(=O)O)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ PDCD1 Q15116 2/20 0.42
▸ CD274 Q9NZQ7 2/20 0.42
▸ GAPDH P04406 2/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ PRKCI P41743 1/20 0.41
▸ PRKCZ Q05513 1/20 0.41
▸ SLC22A12 Q96S37 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ PTPRC P08575 1/20 0.40
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16057489 0.75 NPC1 (0.36) ALDH1A1KDM4EHPGDMAPK1
SCHEMBL14975270 0.75 KDM4E (0.39) ALDH1A1KDM4EPDCD1CD274BRD4
SCHEMBL14975255 0.74 COMT (0.42) KDM4EPDCD1CD274BRD4PTGS2
SCHEMBL16056962 0.74 ESR2 (0.43) ALDH1A1KDM4EPDCD1CD274BRD4
SCHEMBL16056362 0.74 TPMT (0.32) —
SCHEMBL16057503 0.71 MCL1 (0.42) BRD4PPARGPPARA
SCHEMBL16057154 0.70 RAB9A (0.42) ALDH1A1HPGDMAPK14
SCHEMBL16057309 0.69 MCL1 (0.40) ALDH1A1KDM4EPPARG
SCHEMBL16057665 0.69 PLA2G2A (0.43) —
SCHEMBL16057266 0.69 TAF1 (0.49) ALDH1A1KDM4EHPGDPDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782567-B1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) UNIV CALIFORNIA (US) 2017-03-22 — — EP disclosed
US-20160235707-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) FOND ST ITALIANO TECNOLOGIA (IT) 2016-08-18 — — US disclosed
US-9353075-B2 Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-05-31 — — US disclosed
EP-2782567-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) The Regents of The University of California (US) 2014-10-01 — — EP disclosed
US-20130281490-A1 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2013-10-24 — — US disclosed
WO-2013078430-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-05-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281490-A1 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA) NAAA, FAAH, FAAH2 ALDH1A1 1331/4885KDM4E 2759/4885PKM 4323/4885
US-20160235707-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) NAAA, FAAH, FAAH2 ALDH1A1 1331/4885KDM4E 2759/4885PKM 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback